Boston Scientific to Acquire Penumbra in $14.5 Billion Deal

Boston Scientific Acquires Lumenis Surgical Business from Baring Private Equity Asia for $1.07B

March 3, 2021

Medical Devices

Boston Scientific has agreed to acquire the Lumenis Surgical Business from Baring Private Equity Asia/Lumenis for USD 1.07 billion, subject to closing adjustments. The deal transfers Lumenis' surgical laser portfolio and global surgical team (including its Israeli laser center of excellence) to Boston Scientific to bolster its Urology strategy, while Lumenis — still owned by BPEA — will focus on Aesthetics and Vision.

Medtronic to Acquire Scientia Vascular for $550 Million

March 10, 2026

Healthcare Services

Medtronic entered into a definitive agreement to acquire Scientia Vascular in a deal valued at $550 million, subject to customary adjustments and potential earn-out/milestone payments. The acquisition is expected to close in the first half of Medtronic’s fiscal 2027, pending regulatory approvals and other closing conditions.

Boston Scientific Acquires Valencia Technologies

January 12, 2026

Medical Devices

Boston Scientific acquired Valencia Technologies to advance its urology and pelvic health portfolio, adding Valencia’s implantable tibial nerve stimulation technology. The deal is expected to close in the first half of 2026, with financial terms undisclosed.

Boston Scientific to Acquire Preventice Solutions for $925 Million

January 22, 2021

Healthcare Services

Boston Scientific entered into a definitive agreement to acquire Preventice Solutions, a private provider of mobile cardiac health monitoring solutions and services, for an upfront cash payment of $925 million. The deal also includes up to $300 million in potential commercial milestone payments and is expected to close by mid-2021 subject to customary conditions.

Danaher to Acquire Masimo for $9.9 Billion

February 17, 2026

Healthcare Services

Danaher entered into a definitive agreement to acquire Masimo, paying $180 per share in cash for all outstanding shares. The deal values Masimo at approximately $9.9 billion (including assumed indebtedness and net of acquired cash) and is expected to close in the second half of 2026, subject to customary regulatory and shareholder approvals.

Boston Scientific Acquires Axonics, Inc.

November 15, 2024

Medical Devices

Boston Scientific agreed to acquire Axonics, a medical technology company focused on urinary and bowel dysfunction, for $71 per share in cash, valuing the equity at approximately $3.7 billion. The boards approved the transaction, which was expected to close in the first half of 2024, and Boston Scientific later announced the acquisition closed on November 15, 2024.